The association of serum neutrophil markers and acute coronary syndrome

Scandinavian Journal of Immunology

Volumn 76, Issue 2, 2012, Pages 181-187

  Alfakry, Hatem ^a   Sinisalo, Juha ^b   Paju, Susanna ^a   Nieminen, Markku S ^b   Valtonen, Ville ^b   Tervahartiala, Taina ^a   Pussinen, Pirkko J ^a   Sorsa, Timo ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; MYELOPEROXIDASE; NEUTROPHIL COLLAGENASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ACUTE CORONARY SYNDROME; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; PERIODONTAL DISEASE; PERIODONTITIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOGRAPHY; RECURRENT DISEASE; TREATMENT DURATION; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; AGED; BIOLOGICAL MARKERS; HUMANS; MATRIX METALLOPROTEINASE 8; MIDDLE AGED; NEUTROPHILS; PEROXIDASE; RECURRENCE; RISK FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 84864325532     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2012.02718.x     Document Type: Article

References (43)

1. Buhlin K, Gustafsson A, Pockley AG, Frostegard J, Klinge B. Risk factors for cardiovascular disease in patients with periodontitis. Eur Heart J 2003;24:2099-107.
2. Pussinen PJ, Tuomisto K, Jousilahti P, Havulinna AS, Sundvall J, Salomaa V. Endotoxemia, immune response to periodontal pathogens, and systemic inflammation associate with incident cardiovascular disease events. Arterioscler Thromb Vasc Biol 2007;27:1433-9.
3. Higashi Y, Goto C, Hidaka T et al. Oral infection-inflammatory pathway, periodontitis, is a risk factor for endothelial dysfunction in patients with coronary artery disease. Atherosclerosis 2009;206:604-10.
4. Gotsman I, Lotan C, Soskolne WA et al. Periodontal destruction is associated with coronary artery disease and periodontal infection with acute coronary syndrome. J Periodontol 2007;78:849-58.
5. Libby P. Inflammation in atherosclerosis. Nature 2002;420:868-74.
6. Packard RR, Libby P. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem 2008;54:24-38.
7. Buhlin K, Hultin M, Norderyd O et al. Periodontal treatment influences risk markers for atherosclerosis in patients with severe periodontitis. Atherosclerosis 2009;206:518-22.
8. Kuula H, Salo T, Pirila E et al. Local and systemic responses in matrix metalloproteinase 8-deficient mice during Porphyromonas gingivalis-induced periodontitis. Infect Immun 2009;77:850-9.
9. Stefanescu A, Braun S, Ndrepepa G et al. Prognostic value of plasma myeloperoxidase concentration in patients with stable coronary artery disease. Am Heart J 2008;155:356-60.
10. Loria V, Dato I, Graziani F, Biasucci LM. Myeloperoxidase: a new biomarker of inflammation in ischemic heart disease and acute coronary syndromes. Mediators Inflamm 2008;2008:135625.
11. Singh U, Devaraj S, Jialal I. C-reactive protein stimulates myeloperoxidase release from polymorphonuclear cells and monocytes: implications for acute coronary syndromes. Clin Chem 2009;55:361-4.
12. Sorsa T, Tjäderhane L, Konttinen YT et al. Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med 2006;38:306-21.
13. Karakas M, Koenig W, Zierer A et al. Myeloperoxidase is associated with incident coronary heart disease independently of traditional risk factors: results from the MONICA/KORA Augsburg study. J Intern Med 2012;271:43-50.
14. Sorsa T, Tjäderhane L, Salo T. Matrix metalloproteinases (MMPs) in oral diseases. Oral Dis 2004;10:311-8.
15. Tuomainen AM, Nyyssonen K, Laukkanen JA et al. Serum matrix metalloproteinase-8 concentrations are associated with cardiovascular outcome in men. Arterioscler Thromb Vasc Biol 2007;27:2722-8.
16. Ozcaka O, Bicakci N, Pussinen P, Sorsa T, Kose T, Buduneli N. Smoking and matrix metalloproteinases, neutrophil elastase and myeloperoxidase in chronic periodontitis. Oral Dis 2011;17:68-76.
17. Krupinski J, Turu MM, Font MA et al. Increased tissue factor, MMP-8, and D-dimer expression in diabetic patients with unstable advanced carotid atherosclerosis. Vasc Health Risk Manag 2007;3:405-12.
18. Pussinen PJ, Sarna S, Puolakkainen M, Ohlin H, Sorsa T, Pesonen E. The balance of serum matrix metalloproteinase-8 and its tissue inhibitor in acute coronary syndrome and its recurrence. Int J Cardiol 2012; doi:.
19. Sinisalo J, Mattila K, Valtonen V et al. Effect of 3months of antimicrobial treatment with clarithromycin in acute non-q-wave coronary syndrome. Circulation 2002;105:1555-60.
20. Paju S, Pussinen PJ, Sinisalo J et al. Clarithromycin reduces recurrent cardiovascular events in subjects without periodontitis. Atherosclerosis 2006;188:412-9.
21. Rautelin HI, Oksanen AM, Veijola LI et al. Enhanced systemic matrix metalloproteinase response in Helicobacter pylori gastritis. Ann Med 2009;41:208-15.
22. Paju S, Sinisalo J, Pussinen PJ, Valtonen V, Nieminen MS. Is periodontal infection behind the failure of antibiotics to prevent coronary events? Atherosclerosis 2007;193:193-5.
23. Schindhelm RK, van der Zwan LP, Teerlink T, Scheffer PG. Myeloperoxidase: a useful biomarker for cardiovascular disease risk stratification? Clin Chem 2009;55:1462-70.
24. Tavora FR, Ripple M, Li L, Burke AP. Monocytes and neutrophils expressing myeloperoxidase occur in fibrous caps and thrombi in unstable coronary plaques. BMC Cardiovasc Disord 2009;9:27.
25. Ramseier CA, Kinney JS, Herr AE et al. Identification of pathogen and host-response markers correlated with periodontal disease. J Periodontol 2009;80:436-46.
26. Kozarov EV, Dorn BR, Shelburne CE, Dunn WA Jr, Progulske-Fox A. Human atherosclerotic plaque contains viable invasive Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis. Arterioscler Thromb Vasc Biol 2005;25:17-8.
27. Hernandez M, Gamonal J, Tervahartiala T et al. Associations between matrix metalloproteinase-8 and -14 and myeloperoxidase in gingival crevicular fluid from subjects with progressive chronic periodontitis: a longitudinal study. J Periodontol 2010;81:1644-52.
28. Wang Y, Rosen H, Madtes DK et al. Myeloperoxidase inactivates TIMP-1 by oxidizing its N-terminal cysteine residue: an oxidative mechanism for regulating proteolysis during inflammation. J Biol Chem 2007;282:31826-34.
29. Roman RM, Wendland AE, Polanczyk CA. Myeloperoxidase and coronary arterial disease: from research to clinical practice. Arq Bras Cardiol 2008;91:11-9.
30. Esporcatte R, Rey HC, Rangel FO et al. Predictive value of myeloperoxidase to identify high risk patients admitted to the hospital with acute chest pain. Arq Bras Cardiol 2007;89:377-84.
31. van den Borne SW, Cleutjens JP, Hanemaaijer R et al. Increased matrix metalloproteinase-8 and -9 activity in patients with infarct rupture after myocardial infarction. Cardiovasc Pathol 2009;18:37-43.
32. Cheng C, Tempel D, van Haperen R et al. Activation of MMP8 and MMP13 by angiotensin II correlates to severe intra-plaque hemorrhages and collagen breakdown in atherosclerotic lesions with a vulnerable phenotype. Atherosclerosis 2009;204:26-33.
33. Brew K, Dinakarpandian D, Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 2000;1477:267-83.
34. Beaudeux JL, Giral P, Bruckert E, Foglietti MJ, Chapman MJ. Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives. Clin Chem Lab Med 2004;42:121-31.
35. Altenburg J, de Graaff CS, van der Werf TS, Boersma WG. Immunomodulatory effects of macrolide antibiotics - part 1: biological mechanisms. Respiration 2011;81:67-74.
36. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989;320:365-76.
37. Hanemaaijer R, Sorsa T, Konttinen YT et al. Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-alpha and doxycycline. J Biol Chem 1997;272:31504-9.
38. Aoyama N, Suzuki JI, Ogawa M et al. Clarithromycin suppresses the periodontal bacteria-accelerated abdominal aortic aneurysms in mice. J Periodontal Res 2011; doi:
39. Ogawa M, Suzuki J, Hishikari K, Takayama K, Tanaka H, Isobe M. Clarithromycin attenuates acute and chronic rejection via matrix metalloproteinase suppression in murine cardiac transplantation. J Am Coll Cardiol 2008;51:1977-85.
40. Pitiphat W, Crohin C, Williams P et al. Use of preexisting radiographs for assessing periodontal disease in epidemiologic studies. J Public Health Dent 2004;64:223-30.
41. Merchant AT, Pitiphat W, Parker J, Joshipura K, Kellerman M, Douglass CW. Can nonstandardized bitewing radiographs be used to assess the presence of alveolar bone loss in epidemiologic studies? Commun Dent Oral Epidemiol 2004;32:271-6.
42. Mattila K. Does periodontitis cause heart disease? Eur Heart J 2003;24:2079-80.
43. Rutger Persson G, Ohlsson O, Pettersson T, Renvert S. Chronic periodontitis, a significant relationship with acute myocardial infarction. Eur Heart J 2003;24:2108-15.